Evaluation of GvHD Damage on Medullary Mesenchymal Stem Cells
Prospective Multicenter Study for the Evaluation of GvHD Damage on Medullary Mesenchymal Stem Cells - GvHD Damage on MSCs
Sponsor: Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
This observational or N/A phase trial investigates Graft Vs Host Disease and is currently ongoing. Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Jun 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Jun 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jun 2023 — Jul 2024 [monthly]
Recruiting
-
Jan 2022 — Jun 2023 [monthly]
Recruiting
First recorded
Oct 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
For direct contact, visit the study record on ClinicalTrials.gov .